目的:观察中西医结合治疗强直性脊柱炎(AS)的临床疗效.方法:将90例强直性脊柱炎患者随机分为对照组与治疗组,每组45例.对照组仅用西药柳氮磺吡啶片治疗,治疗组采用中药与柳氮磺吡啶片联合治疗.结果:经治疗后,治疗组总有效率为97.78%,对照组为51.11%,两组比较,差异有统计学意义(P<0.01).结论:中药与柳氮磺吡啶片联合治疗强直性脊柱炎疗效显著,不良反应少,值得临床推广使用.01589-901
Ankylosing spondylitis (AS) is a systemic autoimmune disorder that induces ankylosis of the spine (f...
Ankylosing spondylitis (AS) is a complex, potentially debilitating disease that is insidious in onse...
Ankylosing spondylitis is a long term disease that causes inflammation of joints between the vertebr...
Object : This study is designed in order to evaluate oriental medical treatment of ankylosing spondy...
Contains fulltext : mmubn000001_191288209.pdf (publisher's version ) (Open Access)...
Background: Nonsteroidal anti-inflammatory drugs are the first-line option for treating ankylosing s...
The paper characterizes ankylosing spondylitis (AS), one of the common spinal inflammatory diseases,...
published_or_final_versionC Medico-social Problems in Ankylosing Spondylitics R. Leung, P. Leung, E....
Ankylosing spondylitis (AS) is a chronic and progressive systemic disease characterized by the occur...
The aim of the study – to evaluate the effectiveness of pathogenetic therapy in patients with ankylo...
Introduction: Targeted medication, including mostly biologics and small-molecule chemical drugs, is ...
Ankylosing spondylitis is a chronic, gradually progressive inflammatory disease characterized by les...
目的 了解强直性脊柱炎患者治疗依从性现状及其影响因素.方法 对2011年3月-2012年3月在我院风湿免疫科门诊就诊的200例强直性脊柱炎患者建立门诊健康档案,同时进行治疗依从性测评,并对不依从原因进...
International audienceOBJECTIVES: To develop recommendations about pharmacotherapy (excluding biothe...
<p class="MsoNormal"><span lang="EN-US">The literature virtually lacks the results of investigations...
Ankylosing spondylitis (AS) is a systemic autoimmune disorder that induces ankylosis of the spine (f...
Ankylosing spondylitis (AS) is a complex, potentially debilitating disease that is insidious in onse...
Ankylosing spondylitis is a long term disease that causes inflammation of joints between the vertebr...
Object : This study is designed in order to evaluate oriental medical treatment of ankylosing spondy...
Contains fulltext : mmubn000001_191288209.pdf (publisher's version ) (Open Access)...
Background: Nonsteroidal anti-inflammatory drugs are the first-line option for treating ankylosing s...
The paper characterizes ankylosing spondylitis (AS), one of the common spinal inflammatory diseases,...
published_or_final_versionC Medico-social Problems in Ankylosing Spondylitics R. Leung, P. Leung, E....
Ankylosing spondylitis (AS) is a chronic and progressive systemic disease characterized by the occur...
The aim of the study – to evaluate the effectiveness of pathogenetic therapy in patients with ankylo...
Introduction: Targeted medication, including mostly biologics and small-molecule chemical drugs, is ...
Ankylosing spondylitis is a chronic, gradually progressive inflammatory disease characterized by les...
目的 了解强直性脊柱炎患者治疗依从性现状及其影响因素.方法 对2011年3月-2012年3月在我院风湿免疫科门诊就诊的200例强直性脊柱炎患者建立门诊健康档案,同时进行治疗依从性测评,并对不依从原因进...
International audienceOBJECTIVES: To develop recommendations about pharmacotherapy (excluding biothe...
<p class="MsoNormal"><span lang="EN-US">The literature virtually lacks the results of investigations...
Ankylosing spondylitis (AS) is a systemic autoimmune disorder that induces ankylosis of the spine (f...
Ankylosing spondylitis (AS) is a complex, potentially debilitating disease that is insidious in onse...
Ankylosing spondylitis is a long term disease that causes inflammation of joints between the vertebr...